Pharmaceutical companies were pressured by a cartel of pharmacy benefit managers (PBMs) not to do business with Cost Plus Drugs, threatening to cut off their products from the PBMs' distribution channels.
Oshmiansky found Cuban's public Gmail address and sent him an email, which led to a quick response and subsequent investment from Cuban.
The company revealed the true cost of purchasing drugs and added a $15 shipping fee, aiming for transparency in pricing.
By bypassing the traditional distribution chain controlled by PBMs, Cost Plus Drugs can purchase drugs directly from manufacturers at lower prices and pass on the savings to consumers.
The dramatic price increase of a drug by Martin Shkreli, known as the 'pharma bro,' which highlighted the exploitative practices in the pharmaceutical industry.
Advice from Y Combinator's Sam Altman suggested that raising funds as a nonprofit would be difficult, leading Oshmiansky to reincorporate as a public benefit corporation to attract investment.
The company focuses on producing drugs that are in shortage, often neglected by other manufacturers due to low profit margins.
The company employs robotic arms in hermetically sealed chambers that are sterilized by vaporized hydrogen peroxide, allowing for rapid and sterile production of medications.
Practicing radiology provides him with discipline and decision-making skills, reinforcing the importance of taking responsibility and making timely decisions.
The company is working on securing partnerships with major branded pharmaceutical companies like Johnson & Johnson, Bayer, and Pfizer to expand its product offerings.
With the help of co-founder Mark Cuban, Cost Plus Drugs CEO Alex Oshmyansky is radically re-engineering the pharma marketplace and dramatically cutting the price for many prescription drugs. Oshmyansky joins Rapid Response host Bob Safian to share his amazing journey — from struggling as an immigrant in primary school to starting college at age 13, how medical practice led to entrepreneurship, plus reimagining his original plan on advice from the legendary incubator Y Combinator. Oshmyansky explains how CostPlusDrugs stumbled into success, turning adversaries into allies and harnessing patience as a superpower.
For more info, visit: www.rapidresponseshow.com)
See Privacy Policy at https://art19.com/privacy) and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info).